Cita APA

Perez, M., Lucena Cacace, A., Marín Gómez, L. M., Padillo Ruiz, F. J., Robles Frias, M., Saez, C., . . . Carnero Moya, A. (2016). Correction: Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src.

Citación estilo Chicago

Perez, Marco, Antonio Lucena Cacace, Luis Miguel Marín Gómez, Francisco Javier Padillo Ruiz, MJ Robles Frias, Carmen Saez, Rocío García Carbonero, y Amancio Carnero Moya. Correction: Dasatinib, a Src Inhibitor, Sensitizes Liver Metastatic Colorectal Carcinoma to Oxaliplatin in Tumors With High Levels of Phospho-Src. 2016.

Cita MLA

Perez, Marco, et al. Correction: Dasatinib, a Src Inhibitor, Sensitizes Liver Metastatic Colorectal Carcinoma to Oxaliplatin in Tumors With High Levels of Phospho-Src. 2016.